SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2022 quarter is pegged at Rs. 12.16 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended December 2022 of Rs. 16.18 millions grew from Rs.-1.74 millions Operating profit Margin for the quarter ended December 2022 improved to 16.71% as compared to -0.96% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 12.16 0.00 0.00 33.37 0.00 0.00 1.27 0.00 0.00
Other Income 27.89 11.83 135.76 71.89 327.66 -78.06 395.35 296.13 33.51
PBIDT 16.71 -0.96 -1840.63 33.28 287.16 -88.41 339.68 -85.32 -498.12
Interest 0.17 0.27 -37.04 0.58 1.20 -51.67 2.47 5.58 -55.73
PBDT 16.54 -1.23 -1444.72 32.27 134.83 -76.07 36.44 -90.90 -140.09
Depreciation 0.34 0.48 -29.17 1.19 1.43 -16.78 1.92 3.78 -49.21
PBT 16.20 -1.71 -1047.37 31.08 133.40 -76.70 34.52 -94.68 -136.46
TAX 0.02 0.03 -33.33 1.13 -0.36 -413.89 4.96 -0.81 -712.35
Deferred Tax 0.02 0.03 -33.33 1.13 -0.36 -413.89 7.46 -2.91 -356.36
PAT 16.18 -1.74 -1029.89 29.95 133.76 -77.61 29.56 -93.87 -131.49
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 137.42 0.00 0.00 99.73 0.00 0.00 26746.46 0.00 0.00

Ambalal Sarabhai Ent Share Price

31.07 -0.26 (-0.83%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×